Scientific work

Prof. Dr. Evren Özdemir

153 publications. The source of the information is stated next to each publication.

Back to profile

  1. Özdemir E, Basu S, Blough RI, Winkelmann JC. Description of human and murine CD44 homologs; human HAR (hHAR) and murine HAR (mHAR). Turkish Journal of Cancer, 34, 60-66, 2004.

    Source: medicana.com.tr profile page

  2. Dönmez A, Çal Ç, Hekimgil M, Çağırgan S, Şencan M, Özdemir E, Özyurt C, Çıkılı N, Göker E. Prostatic involvement of non-hodgkin lymphoma: Case report. Medical Journal of Ege University, 7, 41-43, 1997.

    Source: medicana.com.tr profile page

  3. Göker E, Özdemir E. Tümör belirteçleri. Spektrum Derlemeler, sf. 19-27, ed. Kaya Emerk, Açılım Yayıncılık, İzmir, 1997.

    Source: medicana.com.tr profile page

  4. Cirit M, Arkun R, Özbek S, Sermez Y, Saydam G, Özdemir E, Töbü M, Başçı A. Ağır sekonder hiperparatiroidili iki üremik hastada perkütanöz ince iğne ethanol enjeksiyonu. Ulusal Endokrinoloji Dergisi, 6, 419-425, 1996.

    Source: medicana.com.tr profile page

  5. Özdemir E, Sebik F. Bronşiyel astımın etiopatojenezi. Akademi, 2, 85-103, 1996.

    Source: medicana.com.tr profile page

  6. Cirit M, Özkahya M, Özdemir E, Başçı A, Atabay G. İki hemodiyaliz hastasında kardiyak tamponadla seyreden pürülan perikardit. Türk Nefroloji Diyaliz ve Transplantasyon Dergisi, 5, 40-42, 1996.

    Source: medicana.com.tr profile page

  7. Saydam G, Cirit M, Özdemir E, Akçiçek F, Atabay G. Metabolik asidoz: kronik böbrek yetmezliğinde anlamlı bir katabolik faktör. SSK İzmir Eğitim Hastanesi Tıp Dergisi, 1, 39-40, 1995.

    Source: medicana.com.tr profile page

  8. Özdemir E, Akçiçek F. Renal transplantasyonda immünosupresif tedavi. Akademi, 2, 79-96, 1995.

    Source: medicana.com.tr profile page

  9. Ok E, Özdemir E, Akçiçek F, Yönetçi N, Töbü M, Cirit M, Atabay G, Batur Y. Hemodiyaliz Ünitesinde HBV ve HCV enfeksiyonu prevelansındaki değişiklikler. T Klin Gastroenterohepatoloji, 5, 188-191, 1994.

    Source: medicana.com.tr profile page

  10. Ok E, Töbü M, Özdemir E, Akçiçek F, Tokat Y, Bor S, Atabay G, Batur Y. Renal allograft alıcılarında HBV, HCV ve HDV enfeksiyonları. Gastroenteroloji, 5, 642-646, 1994.

    Source: medicana.com.tr profile page

  11. Özdemir E, Turker A, Barısta I, Kars A. The lollipop with strawberry aroma significantly reduces infusion-related nausea and vomiting during the infusion of cryopreserved peripheral blood stem cells: A randomized study. Submitted to Biol Blood Marrow Transplant, 2020.

    Source: medicana.com.tr profile page

  12. Özdemir E, Turker A, Barısta I, Kars A. Gemcitabine in combination with oxaliplatin (GemOx) as a salvage regimen in patients with relapsed/refractory Hodgkin’s lymphoma. Submited to Clinical Lymphoma, Myeloma & Leukemia, 2020.

    Source: medicana.com.tr profile page

  13. Özdemir E, Turker A, Barısta I, Kars A. Weekly Paclitaxel and Carboplatin as a salvage regimen in patients with relapsed/refractory Hodgkin’s lymphoma. Submited to Leukemia & Lymphoma, 2020.

    Source: medicana.com.tr profile page

  14. Özbalak M, Salihoğlu A, Soysal T, Karadoğan İ, Paydaş S, Özdemir E, Yıldız B, Karadurmuş N, Kaynar L, Yagci M, Özkocaman V, Topçuoğlu P, Özcan M, Birtaş E, Göker H, Ferhanoglu B. Long term results of brentuximab vedotin in relapsed and refractory Hodgkin lymphoma: multi-center real-life experience. Ann Hematol. 99(2):301-307, 2020.

    Source: medicana.com.tr profile page

  15. Okay M, Aslan T, Özdemir E, Uner A, Saglam A, Gungor E, Uysal A, Alayvaz Aslan N, Yildizhan E, Agit A, Dal MS, Korkmaz S, Namdaroglu S, Sivgin S, Akgun Cagliyan G, Demircioglu S, Barista I, Ozhamam E, Vural F, Eser B, Ozet G, Yildirim R, Dogu MH, Berber I, Erkurt MA, Malkan UY, Altuntas F, Buyukasik Y. Splenic Marginal Zone Lymphoma in Turkey: Association with Hepatitis B Instead of Hepatitis C Virus as an Etiologic and Possible Prognostic Factor-Multicenter Cohort Study. Turkish Journal of Hematology Oct. 21, 2019.

    Source: medicana.com.tr profile page

  16. Aerts-Kaya F, Koca G, Sharafi P, Sayla FC, Akbiyik F, Uckan-Cetinkaya D, Özdemir E. Automated washing of long-term cryopreserved peripheral blood stem cells promotes cell viability and preserves CD34+ cell numbers. Bone Marrow Transplant. 53(9):1225-1227, 2018.

    Source: medicana.com.tr profile page

  17. Connors JM, Jurczak W, Straus DJ, Ansell SM, Kim WS, Gallamini A, Younes A, Alekseev S, Illés Á, Picardi M, Lech-Maranda E, Oki Y, Feldman T, Smolewski P, Savage KJ, Bartlett NL, Walewski J, Chen R, Ramchandren R, Zinzani PL, Cunningham D, Rosta A, Josephson NC, Song E, Sachs J, Liu R, Jolin HA, Huebner D, Radford J; ECHELON-1 Study Group. Brentuximab Vedotin with Chemotherapy for Stage III and IV Hodgkin’s Lymphoma. N Engl J Med. 378(4):331-344, 2018. Aslan A, Arat T, Özdemir E. Successful Treatment of Relapsed/Refractory Hodgkin’s Lymphoma with Nivolumab in a Heavily Pretreated Patient with Progressive Disease after Both Autologous and Allogeneic Stem Cell Transplantation. Leuk Lymphoma. 58(3):754-755, 2017.

    Source: medicana.com.tr profile page

  18. Sarici F, Kertmen N, Aslan A, Tasdemir V, Babacan T, Kilickap S, Özdemir E, Barista I, Turker A, Kars A. Antracyclin-Based Chemotherapy in Patients with Non-Hodgkin’s Lymphoma Aged over 75. International Journal of Hematology and Oncology 26(2):1-7, 2016.

    Source: medicana.com.tr profile page

  19. Tekgunduz E, Goker H, Kaynar L, Sarı I, Pala C, Dogu MH, Ozturk E, Turgut B, Korkmaz S, Tetik A, Buyukasık Y, Hacıoglu SK, Bozdag SC, Özdemir E, Altuntas F. Adult Philadelphia chromosome-positive acute lymphoblastic leukemia in daily practice: A multicenter experience. Clin Lymphoma Myeloma Leuk. 16(5):269-274, 2016.

    Source: medicana.com.tr profile page

  20. Aksu A, Ayyildiz O, Etgul S, Goker H, Gunes G, Haznedaroglu IC, Ilhan O, Kaynar LG, Malkan UY, Özdemir E, Saydam G, Sayinalp N, Sahin F, Turgut M, Unal A. Idelalisib at the Crossroads of B-Cell Lymphoproliferative Disorders. International Journal of Hematology and Oncology 26(2): 12-19, 2016.

    Source: medicana.com.tr profile page

  21. Salihoglu A, Elverdi T, Karadogan I, Paydas S, Özdemir E, Erdem G, Karadurmuş N, Akyol G, Kaynar L, Yegin ZA, Sucak G, Ozkocaman V, Topcuoglu P, Ozcan M, Birtas E, Goker H, Baslar Z, Ferhanoglu B. Bretuximab vedotin for relapsed or refractory Hodgkin lymphoma: experience in Turkey. Ann Hematol. 94(3):415-20, 2015.

    Source: medicana.com.tr profile page

  22. Bayraktar-Ekincioglu A, Demirkan K, Keskin B, Aslantaş O, Özdemir E. Potential drug interactions and side effects in an outpatient oncology clinic: a retrospective descriptive study. Eur J Hosp Pharm 21:216-221, 2014.

    Source: medicana.com.tr profile page

  23. Ayyıldız O, Demirkan F, Goker H, Haznedaroglu IC, Ilhan O, Kaynar LG, Özdemir E, Saydam G, Sayınalp N, Sahin F, Turgut M, Unal A, Vural F. Ibrutinib: From molecule to medicine. International Journal of Hematology and Oncology 3(1):24, 2014.

    Source: medicana.com.tr profile page

  24. Goker H, Özdemir E, Uz B, Buyukasik Y, Turgut M, Serefhanoglu S, Aksu S, Sayinalp N, Haznedaroglu IC, Tekin F, Karacan Y, Unal S, Eliacik E, Isik A, Ozcebe OI. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: A single center experience. Transfus Apher Sci. August 8, 2013.

    Source: medicana.com.tr profile page

  25. Buyukasik Y, Acar K, Kelkitli E, Uz B, Serefhanoglu S, Özdemir E, Pamukcuoglu M, Atay H, Bektas O, Sucak GT, Turgut M, Aksu S, Yagci M, Sayınalp N, Ozcebe OI, Goker H, Haznedaroglu IC. Hyper-CVAD regimen in routine management of adult lymphoblastic leukemia: A retrospective multicenter study. Acta Haematologica 130:199-205, 2013.

    Source: medicana.com.tr profile page

  26. Özdemir E, Kansu E. Deep vein thrombosis following non-myeloablative allogeneic stem cell transplantation: Presentation of three cases and literature review. Turkish Journal of Hematology 30:188-190, 2013.

    Source: medicana.com.tr profile page

  27. Camurdanoglu BZ, Esendaglı G, Özdemir E, Canpınar H, Guc D, Kansu E. The effect of granulocyte colony stimulating factor receptor gene missense single nucleotide polymorphisms on peripheral blood stem cell enrichment. Cytokine Nov 15, 2012.

    Source: medicana.com.tr profile page

  28. Uz B, Özdemir E, Aksu S, Akyol TK, Jones R. Successful treatment of autoimmune hemolytic anemia with steroid, IVIG, and plasmapheresis in a haploidentical transplant recipient. Turkish Journal of Hematology 29:199-200, 2012.

    Source: medicana.com.tr profile page

  29. Arslan C, Özdemir E, Dogan E, Ozisik Y, Altundag K. Secondary hematological malignancies after treatment of non-metastatic breast cancer. Journal of BUON 16:744-750, 2011.

    Source: medicana.com.tr profile page

  30. Ozmen F, Ozmen MM, Özdemir E, Moran M, Seckin S, Guc D, Karaagaoglu E, Kansu E. Relationship between LYVE-1, VEGFR-3 and CD44 gene expressions and lymphatic metastasis in gastric cancer. World J. Gastroenterol. 17(27):3220-8, 2011. Kara O, Özdemir E, Arslan C, Dogan E, Altundag K. Acute promyelocytic leukemia in a young patient with breast cancer. Med Oncol. 28(1):249-50, 2011.

    Source: medicana.com.tr profile page

  31. Firat F, Ozen G, Yildiz G, Saglam A, Onder S, Tan E, Özdemir E. Late relapse of acute myeloblastic leukemia as myeloid sarcoma causing radiculopathy. Leuk Res. 34(12): e348-350, 2010.

    Source: medicana.com.tr profile page

  32. Ararat E, Sahin I, Özdemir E, Altundag K. Mechanisms behind the anti-tumour effects of zoledronic acid use in multiple myeloma. Br J Haematol. 151(5):530-531, 2010.

    Source: medicana.com.tr profile page

  33. Arik Z, Ozkan C, Özdemir E, Altundag K. Breast cancer in a patient with agnogenic myeloid metaplasia. Souh Med J. 103(10):1075-1076, 2010.

    Source: medicana.com.tr profile page

  34. Serefhanoglu S, Buyukasık Y, Goker H, Sayinalp N, Haznedaroglu IC, Aksu S, Ozcebe OI, Turgut M, Aslan R, Özdemir E. Clinical Features and outcomes of 49 Turkish patients with acute promyelocytic leukemia who received ATRA and antracyclines (PETHEMA protocol) therapy. Leuk Res. 34(12): e317-319, 2010.

    Source: medicana.com.tr profile page

  35. Özdemir E, Bayraktar M, Sokmensuer C, Kir KM, Kansu E. Late relapse of a light chain myeloma as extramedullary plasmacytoma of the thyroid gland after second allogeneic stem cell transplantation. Clinical Transplantation 23(6): 981-984, 2009.

    Source: medicana.com.tr profile page

  36. Oyan B, Koc Y, Özdemir E, Kars A, Turker A, Tekuzman G, Kansu E. High complete remission rate and durable remissions achieved with rational use of autologous stem cell transplantation, thalidomide maintenance, and non-myeloablative allogeneic transplantation in patients with multiple myeloma. Clinical Transplantation 23(6): 839-847, 2009.

    Source: medicana.com.tr profile page

  37. Özdemir E, Akgedik K, Akdogan S, Kansu E. The lollipop with strawberry aroma may be promising in reduction of infusion-related nausea and vomiting during the infusion of cryopreserved peripheral blood stem cells. Biol Blood Marrow Transplant 14(12):1425-8, 2008.

    Source: medicana.com.tr profile page

  38. Özdemir E, Saliba RM, Champlin RE, Couriel DR, Giralt SA, de Lima M, Khouri IF, Hosing C, Kornblau SM, Anderlini P, Shpall EJ, Qazilbash MH, Molldrem JJ, Chemaly RF, Komanduri KV. Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignancies. Bone Marrow Transplantation 40:125-136, 2007.

    Source: medicana.com.tr profile page

  39. Dizdar Ö, Özdemir E, Üner A, Kansu E. Images in hematology-oncology: A 40-year-old female presenting with a solitary pulmonary nodule. Turkish Journal of Cancer 36, 35-37, 2006.

    Source: medicana.com.tr profile page

  40. Oyan B, Koc Y, Özdemir E, Kars a, Turker A, Tekuzman G, Kansu E. High dose sequential chemotherapy and autologous stem cell transplantation in patients with relapsed/refractory lymphoma. Leukemia and Lymphoma, 47(8): 1545-1552, 2006.

    Source: medicana.com.tr profile page

  41. Özdemir E, Molldrem JJ. Hookworm infection of sigmoid colon masquerading as graft-versus-host disease in an allogeneic stem cell transplant recipient after donor lymphocyte infusion for refractory acute promyelocytic leukemia. Bone Marrow Transplantation, 37, 785-786, 2006.

    Source: medicana.com.tr profile page

  42. Özdemir E, Koc Y, Kansu E. Successful treatment of chronic myeloid leukemia with imatinib mesylate in a patient with chronic renal failure on hemodialysis. American Journal of Hematology, 81(6), 474, 2006.

    Source: medicana.com.tr profile page

  43. Oyan B, Koc Y, Özdemir E, Kars A, Turker A, Tekuzman G, Kansu E. Ifosfamide, Idarubicin, and Etoposide in Relapsed/Refractory Hodgkin’s Disease or Non-Hodgkin Lymphoma: A Salvage Regimen with High Response Rates before Autologous Stem Cell Transplantation. Biology of Blood and Marrow Transplantation, 11, 688-697, 2005.

    Source: medicana.com.tr profile page

  44. Özdemir E, Basu S, Blough RI, Winkelmann JC: Description of human and murine CD44 homologs; human HAR (hHAR) and murine HAR (mHAR). Turkish Journal of Cancer, 34(2):60-66, 2004.

    Source: medicana.com.tr profile page

  45. Özdemir E, St. John LS, Molldrem JJ, Gillespie G, Champlin RE, Rowland-Jones S, Komanduri KV. Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8+ T cells. Blood, 100, 3690-3697, 2002.

    Source: medicana.com.tr profile page

  46. Çağırgan S, Şencan M, Tombuloğlu M, Özdemir E, Hekimgil M, Büyükkeçeci F. Two Consecutive Spontaneous Regressions to Chronic Phase in a Patient with Blastic Transformation of Chronic Myelogenous Leukemia. Leukemia and Lymphoma, 29, 423-425, 1998.

    Source: medicana.com.tr profile page

  47. Kocanogulları H, Özdemir E, Keser G, Tuncbay T, Gumusdis G, Doganavsargil E. Focal Myositis. Clin Rheumatol, 17, 65-67, 1998.

    Source: medicana.com.tr profile page

  48. Çağırgan S, Şencan M, Dönmez A, Özdemir E, Tombuloğlu M, Büyükkeçeci F. A case report: Chronic lymphocytic leukemia with widespread osteolytic lesions. Turkish Journal of Haematology, 14, 113-115, 1997.

    Source: medicana.com.tr profile page

  49. Özdemir E. Aplastik Anemi ve Miyelodisplastik Sendromda Febril Nötropeni. Bölüm 4: Özel durumdaki immünkompromize hastalar, Febril Nötropeni, Editörler: Murat Akova, Hamdi Akan, Bilimsel Tıp Yayınevi, 2010, S:321-331.

    Source: medicana.com.tr profile page

  50. Özdemir E. Kanser tedavisinin yan etkileri. Hacettepe Üniversitesi Tıp Fakültesi Sağlık Ansiklopedisi Editör: Prof. Dr. İskender Sayek, Güneş Tıp Kitabevleri, sayfa:367-369, 2008.

    Source: medicana.com.tr profile page